RAC1 and schistosomiasis: Taken together, this study demonstrates that primed MSCs attenuate schistosomiasis liver fibrosis by enhancing macrophage subset switch and efferocytosis via Itgb2-Rac1 axis, which offers novel insights into the therapeutic targets of MSC-based anti-fibrotic therapy.